Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jul 1;29(4):455-459.
doi: 10.1097/MJT.0000000000001520.

Re: Expression of Concern for Bryant A, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection. Am J Ther. 2022;29:e232

Andrew Bryant  1 , Theresa A Lawrie  2 , Edmund J Fordham  2 , Scott Mitchell  2
Affiliations
Comment

Re: Expression of Concern for Bryant A, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection. Am J Ther. 2022;29:e232

Andrew Bryant et al. Am J Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

FIGURE 1.
FIGURE 1.
Updated mortality meta-analysis including all qualifying trials.
FIGURE 2.
FIGURE 2.
Updated mortality meta-analysis excluding Elgazzar.
FIGURE 3.
FIGURE 3.
Updated mortality analysis with exclusions of both Elgazzar and Niaee.
See this image and copyright information in PMC

Comment on

References

    1. Manu P. Expression of concern for Bryant A, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for prevention and treatment of COVID-19 infection. Am J Ther. 2022;29:e232. - PMC - PubMed
    1. Rothrock SG, Weber KD, Giordano PA, et al. . Meta-analyses do not establish improved mortality with ivermectin use in COVID-19. “Commentary”. Am J Ther. 2021;29:e87–e94. - PubMed
    1. Bryant A, Lawrie TA, Dowswell T, et al. . Ivermectin for prevention and treatment of COVID-19 infection: a systematic review, meta-analysis, and trial sequential analysis to inform clinical guidelines. Am J Therap. 2021;28:e434–e460. - PMC - PubMed
    1. Bryant A, Lawrie TA, Fordham EJ. Ivermectin for prevention and treatment of COVID-19 infection: a systematic review, meta-analysis, and trial sequential analysis to inform clinical guidelines. Am J Ther. 2021;2828:e434–e460, e573–e576. - PMC - PubMed
    1. Elgazzar A, Hany B, Youssef SA, et al. . Efficacy and safety of ivermectin for treatment and prophylaxis of COVID-19 pandemic. Res Square. 2020. Preprint. doi: 10.21203/rs.3.rs-100956/v2. - DOI